Analyst firms · BTIG · ORGO
BTIG ORGO price target and rating history
Organogenesis Holdings Inc. (ORGO) · Health Care
BTIG rates Organogenesis Holdings Inc. (ORGO) Neutral with a $10 price target, as of its latest action on May 8, 2026. It has published 3 rating actions on ORGO since November 2022, including 1 upgrade and 2 downgrades.
- Current rating
- Neutral
- Price target
- $10
- Median target, all firms
- Too few
- Actions on ORGO
- 3
Every BTIG rating on ORGO
- May 8, 2026DowngradeBTIG downgrades to Neutral from Buy
- May 24, 2023
- Nov 10, 2022DowngradeBTIG downgrades to Neutral from Buy
How other firms rate ORGO
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Truist Securities | Hold | $3 | May 28, 2026 |
| BTIG | Neutral | May 8, 2026 |
Questions about BTIG and ORGO
- What is BTIG's price target for ORGO?
- BTIG's latest stated price target for Organogenesis Holdings Inc. (ORGO) is $10, from its action on May 24, 2023.
- What is BTIG's rating on ORGO?
- BTIG rates ORGO Neutral, a neutral rating, as of May 8, 2026.
- When did BTIG last change its view on ORGO?
- On May 8, 2026, BTIG downgrades to Neutral from Buy.
All BTIG ratingsORGO news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.